<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02074033</url>
  </required_header>
  <id_info>
    <org_study_id>30121978</org_study_id>
    <nct_id>NCT02074033</nct_id>
  </id_info>
  <brief_title>Errors in Prescription Antibiotics in Ventilator-associated Pneumonia</brief_title>
  <official_title>Determination of Errors in Prescription Antibiotics in Ventilator-associated Pneumonia in Unit of Intensive Care of Clinical Hospital of Federal University of Uberlandia - Brazil</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of Uberlandia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of Uberlandia</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The infection is a major risk to hospitalized patients, especially those admitted to the
      Intensive Care Unit (ICU) and an unfavorable factor in the outcome of critically ill
      patients, increasing costs and prolonging hospitalization hospitalar. The
      ventilator-associated pneumonia (PAV) is considered the most prevalent nosocomial infection
      in the ICU, occurring in 9% to 68% of patients with prosthetic ventilatória.Due to the high
      rate of PAV and mortality related to it, is very important both prescription and
      administration of antibiotics correctly, as deescalation or escalation according the result
      of cultures.Therefore, the objectives of this study is assess if whether the antibiotic
      prescribed of ventilator-associated pneumonia following the orientation of literature. Will
      also be assessed the rate of PAV in patients critically ill adults, the main microorganisms
      responsible by PAV and determining antimicrobial susceptibility.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In patients who had a diagnosis of ventilator-associated pneumonia by asssistente physician
      will be assessed initially prescribed antibiotics empirically and what conduct adopted after
      culture results.

      We will be examined whether the antibiotic prescribed following the orientation of
      literature, considering the dose, interval between doses, dose adjustment for renal failure
      infusion time, treatment time and conduct after the culture results (deescalation, escalation
      or maintenance of antimicrobial initially prescribed ) . The deescalation consists of
      discontinuing the use of antimicrobial or antibiotic change to another with lower coverage
      and spectrum is performed, escalation occurs when adding a new antibiotic or antibiotic to
      change the coverage of other larger spectrum after culture results .
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">October 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Determination of Errors in Prescription Antibiotics in Ventilator-associated Pneumonia in Unit of Intensive Care of Clinical Hospital of Federal University of Uberlandia - Brazil</measure>
    <time_frame>six months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">130</enrollment>
  <condition>Pneumonia</condition>
  <arm_group>
    <arm_group_label>antibiotics for pneumonia</arm_group_label>
    <description>We will be examined whether the antibiotic prescribed following the orientation of literature, considering the dose, interval between doses, dose adjustment for renal failure infusion time, treatment time and conduct after the culture results (deescalation, escalation or maintenance of antimicrobial initially prescribed )</description>
  </arm_group>
  <biospec_descr>
    <textblock>
      No samples will be retained for the study
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The study is a retrospective study to evaluate the use of antibiotics in the
        ventilator-associated pneumonia (PAV) in the Intensive Care Unit of the Adult Clinical
        Hospital of the Federal University of Uberlândia. The UnitAdult Intensive Care has
        complexity level III and consists of 30 beds.O number of statistically significant sample
        is 130 patients.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be 18 years of age;

          -  Having the diagnosis of ventilator-associated pneumonia.

        Exclusion Criteria:

          -  Be under 18 years of age;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ana Carolina Souza Oliveira</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Uberlandia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Denise Von Dollinger de Brito</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Uberlandia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thúlio Marquez Cunha</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Uberlandia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabiola Alves Gomes</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Uberlandia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ana Carolina Souza Oliveira</last_name>
    <phone>055343182150</phone>
    <email>acsouzao@yahoo.com.br</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ana Carolina Souza Oliveira</name>
      <address>
        <city>Uberlândia</city>
        <state>Minas Gerais</state>
        <zip>38405322</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Denise Von Dollinger de Brito</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ana Carolina Souza Oliveira</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thúlio Marquez Cunha</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fabiola Alves Gomes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia. American Journal of Respiratory and Critical Care Medicine, New</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>ALVAREZ-LERMA, F. et al. Empiric broad-spectrum antibiotic therapy of nosocomial pneumonia in the intensive care unit: A prospective observational study. Crit Care, London, v.10, n.3, p.1-11, May 2006.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>ANGUS, D.C.et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associa¬ted costs of care. Crit Care Med, New York, v.29, n.7, p.1303-1310, Jul 2001.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>BURKE, J.P. Infection control- a problem for patient safety. N Engl J Med, Melbourn, v.348, n.7, p. 651-656, Feb 2003.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>CAMARGO, L. F. A. et al. Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates. Critical Care Medicine, New York, v.8, n.6, p. 422-430, Dec 2004.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>EACHEMPATI, S.R. et al. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients? J Trauma, Baltimore, v.66, n.5, p.1343-1348, May 2009.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>ERBAY, A., BODUR, H., AKINCI, E., ÇOLPAN, A. Evaluation of antibiotic use in intensive care units of a tertiary care hospital in Turkey. Journal of Hospital Infection, New York , v.59, p.53-61, Jan 2005.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>GOMES SILVA, B.N. et al. De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev, Oxford,v.8, n.12, CD007934, Dec 2010.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>HEENEN, S., JACOBS, F., VINCENT,J-P. Antibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often? Crit Care Med, New York, v.40, n.5, p.1404-1409, May 2012 .</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>RELLO, J. et al. De-escalation therapy in ventilator associated pneumonia. Crit Care Med , New York, v.32, n.11, p.2183-2190, Nov 2004.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>SAFDAR, N.; CRNICH, C.J.; MAKI, D.G. The Pathogenesis of Ventilator-Associated Pneumonia: Its Relevance to Developing Effective Strategies for Prevention. Respiratory Care, Philadelphia, v.50, n.6, p.725-739, Jun 2005.</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed</url>
    <description>WAELE, J.J.D.et al. De-escalation after empirical meropenem treatment in the intensive care unit: Fiction or reality? Journal of Critical Care, Orlando, v.25, n.4, p.641-646, Jan 2010.</description>
  </link>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2014</study_first_submitted>
  <study_first_submitted_qc>February 27, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 28, 2014</study_first_posted>
  <last_update_submitted>March 26, 2014</last_update_submitted>
  <last_update_submitted_qc>March 26, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 27, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federal University of Uberlandia</investigator_affiliation>
    <investigator_full_name>Ana Carolina Souza Oliveira</investigator_full_name>
    <investigator_title>graduate student</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Ventilator-Associated</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

